Cytokinetics filed required disclosures with the SEC under a Rule 10b5-1 trading plan on June 23, 2026.
2 reports, 2 independent
Updated Jul 14
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cytokinetics filed required disclosures with the SEC under a Rule 10b5-1 trading plan on June 23, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Cytokinetics disclosed stock sales under trading plan.1 source
Cytokinetics filed under Rule 10b5-1 trading plan.1 source
Keep exploring
The entities involved
-
Cytokinetics
company in South San Francisco, United States
-
SEC
Slovak company
Related events
- LifeStance Health Group filed disclosures with the SEC regarding stock purchases on September 6, 2026.
- CNO Financial Group, Inc. filed insider trading disclosures with the SEC.
- BrightSpring Health Services filed a disclosure with the SEC on August 17, 2026.
- Global Interactive Technologies, Inc. was listed on the electronic stock exchange and required to file disclosures with the SEC on August 15, 2026.
- The Securities and Exchange Commission (SEC) has issued a requirement regarding the disclosure of fund purchases.